drugset / Trial / NCT07819188
SCTB35 and SCTB41 With or Without Chemotherapy in Non-Hodgkin Lymphoma
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the pharmacokinetics, safety, tolerability and efficacy of SCTB35 and SCTB41 With or Without Chemotherapy in non-Hodgkin's lymphoma patients.
Timeline
- Start
- 2026-09-30
- Primary completion
- 2028-09-30
- Completion
- 2029-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SCTB35 | Unknown | — | Subcutaneous |
| Subject | SCTB41 | Unknown | — | Intravenous |